Evidence map›Paper›PMID 31120972›Full record

ArticlePloS one2019

Adolescents' first tobacco products: Associations with current multiple tobacco product use.

Sarah D Kowitt, Adam O Goldstein, Erin L Sutfin, Amira Osman, Clare Meernik, Courtney Heck, Leah M Ranney

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Assessing Awareness, Ever Use of E-cigarettes and Effect of a Health Education Intervention among Adolescent School Students of Hyderabad.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Sarah D KowittDepartment of Family Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.ORCID 0000-0001-5216-3897
Adam O GoldsteinDepartment of Family Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Erin L SutfinDepartment of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
Amira OsmanDepartment of Family Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Clare MeernikDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Courtney HeckNorth Carolina Department of Health and Human Services, Tobacco Prevention and Control Branch, Raleigh, NC, United States of America.
Leah M RanneyDepartment of Family Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
University of North Carolina at Chapel Hill · USNC Department of Health and Human Services · USWake Forest University · US

Funding

Training & Education Program p294-308P50CA180907 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RIBISL, KURT M. · 2013 to 2017
$20.2M
NCCDPHP CDC HHS U58 DP005974NCI NIH HHS P50 CA180907
6 · The paper itself

Abstract

Understanding which tobacco products adolescents use first can lead to insights for tobacco prevention interventions and policies. We used cross-sectional data from high school students who reported ever using a tobacco product from the 2017 North Carolina Youth Tobacco Survey (n = 1,053). In multivariable regressions, we examined how demographic and psychosocial factors were associated with adolescents' first product tried and how first product tried was associated with current tobacco use (i.e., no use, use of a single product, use of multiple products) and frequency of tobacco use. Cigarettes (34.8%) and e-cigarettes (33.7%) were the most frequently reported first products tried, followed by cigars (15.6%), smokeless tobacco (10.7%), waterpipe (4.0%), and other tobacco products (i.e., pipe tobacco or some other tobacco product) (1.2%). Demographic differences in adolescents' first product tried existed, with Black adolescents having higher odds of initiating tobacco use via cigars (aOR: 6.17, 95% CI: 3.75, 10.14). Adolescents who initiated tobacco use via cigars (aOR: 2.33, 95% CI: 1.31, 4.13) or smokeless tobacco (aOR: 2.45, 95% CI: 1.18, 5.04) had higher odds of being a multiple current tobacco product user, whereas adolescents who initiated tobacco use via e-cigarettes (aOR: 0.57, 95% CI: 0.34, 0.93) had lower odds of being a multiple current tobacco product user. Additionally, adolescents who initiated tobacco use via smokeless tobacco had higher odds of currently using at least one tobacco product frequently (aOR: 1.90, 95% CI: 1.04, 3.48), while adolescents who initiated tobacco use via e-cigarettes had lower odds of currently using at least one tobacco product frequently (aOR: 0.40, 95% CI: 0.23, 0.70). These findings suggest that most adolescents reported initiating tobacco use via cigarettes or e-cigarettes and that trying certain products first (e.g., cigars, smokeless tobacco) was associated with higher odds of multiple current tobacco product use.

Indexed as

Tobacco ProductsAdolescentCross-Sectional StudiesElectronic Nicotine Delivery SystemsFemaleHumansLogistic ModelsMaleMultivariate AnalysisNorth CarolinaOdds RatioPsychology, AdolescentSmokingSmoking PreventionStudentsSurveys and Questionnaires

Identifiers

PMID31120972
PMCPMC6532893
OpenAlexW2946133381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.